Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin

BACKGROUND: Dysregulation of microRNAs has been reported to be responsible for drug resistance of cancers. However, the association between aberrant expression of miR-26b and cisplatin resistance in non-small cell lung cancer (NSCLC) remains unclear. METHODS: PC9 and A549 were used to establish the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Shuzhi, Zhao, Shasha, Gao, Xinyuan, Li, Yunxia, Zhong, Chunlei, Gao, Jianlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751336/
https://www.ncbi.nlm.nih.gov/pubmed/31686855
http://dx.doi.org/10.2147/OTT.S212649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751336/
https://www.ncbi.nlm.nih.gov/pubmed/31686855
http://dx.doi.org/10.2147/OTT.S212649

Ejemplares similares